About

Publications While At HealthPartners

selected publications

Journal Article

Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 

Diabetes Technology & Therapeutics. 2024

Assessing time in range with postprandial glucose-focused titration of ultra rapid lispro (URLi) in people with type 1 diabetes. 

Diabetes Therapy. 2023

Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2022

How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System. 

Diabetes Research and Clinical Practice. 2022

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 

JAMA. 2021

Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 

Diabetes care. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 

Diabetes care. 2021

Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 

JAMA. 2020

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. 

Lancet (London, England). 2019

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 

The lancet. Diabetes & endocrinology. 2017

REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 

Diabetes care. 2017

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 

Diabetes care. 2016

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial. 

Diabetes care. 2013

Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. 

Current Medical Research and Opinion. 2011

Contact

full name

A. Bhargava

Quick Info

 

Collaboration

Co-author network

Map of science